相关实验视频

Updated: Jul 4, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

急性冠状动脉综合征中的丧:与其持久性相关的治疗和预测因素

Sara Gostoli¹, Regina Subach¹, Francesco Guolo²

¹Department of Psychology "Renzo Canestrari", University of Bologna, Viale Berti Pichat 5, 40127 Bologna, Italy.

International journal of clinical and health psychology : IJCHP

|February 6, 2024

概括

认知行为和幸福疗法 (CBT/WBT) 与标准护理相比,有效地减少了急性冠状动脉综合征 (ACS) 患者的丧. 身体化和抑郁症史预测持续的士气丧失,而积极的关系提供了保护.

科学领域:

心脏病学心脏病学
精神病学是一个精神病学.
精神病体医学是一种精神病体医学.

背景情况:

丧气与急性冠状动脉综合征 (ACS) 患者的不良结果有关,但其治疗往往被忽视.
对心脏病患者的精神衰弱进行有效的干预对于改善患者的福祉和预后至关重要.

研究的目的:

为了评估连续认知行为和幸福疗法 (CBT/WBT) 与临床管理 (CM) 对ACS患者精神衰弱的有效性.
为了确定患者的特征,预测在3个月的随访期持续丧.

主要方法:

一项随机对照试验,涉及91名精神衰弱的ACS患者,他们被分配给CBT/WBT (n=47) 或CM (n=44).
在基线,治疗后和3个月的随访期间,使用精神病学研究采访的诊断标准来评估丧.
分析包括心脏参数,心理困扰和幸福感作为潜在的抑郁维护预测因素.

主要成果:

与CM相比,CBT/WBT显著减少了治疗后的丧.
人体化 (OR=1.11,p=0.027) 和抑郁病史 (OR=5.16,p=0.004) 是持续丧的重要危险因素.
积极的社会关系 (OR=0.94,p=0.005) 成为对持续的士气丧失的保护因素.

结论:

序列性CBT/WBT在治疗ACS患者的丧方面表现出有希望的疗效.
识别有体化或有抑郁病史的ACS患者对于积极管理持续的丧至关重要.
培养积极的关系可能会减轻这一群体持续丧的风险.

关键词:

急性冠状动脉综合征是什么认知行为疗法是一种认知行为疗法.堕落和丧失士气的情况.精神病学研究的诊断标准.幸福疗法是一种幸福疗法.

更多相关视频

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

相关概念视频

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Imbalances in Cardiac Output

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...